---
layout: post
title: "Vir Biotechnology盘前涨2.3% 单克隆抗体疗法Sotrovimab对奥密克戎BA.2亚种有效"
date: 2022-02-14 17:20:24 +0800
categories: gelonghui
tags: 格隆汇新闻
---
<p>Vir Biotechnology(VIR.US)盘前涨2.3%，报32.8美元。葛兰素史克此前披露，与Vir Biotechnology联合开发的单克隆抗体疗法Sotrovimab对奥密克戎BA.2亚种有效。</p>
 <center><img src="https://dfscdn.dfcfw.com/download/D25320199734844981760_w520h397.jpg" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p class="em_media">（文章来源：格隆汇）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202142275885114>

[返回格隆汇新闻](//finews.withounder.com/category/gelonghui.html)｜[返回首页](//finews.withounder.com/)